IPO registrations (S-1, F-1) · Registrants
Cingulate Inc.
- SEC CIK
- 1862150 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-09-09, last 2025-07-25; 10 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2021-12-09; declared effective 2021-12-07; withdrawal requested 2023-03-30
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1901 W. 47TH PLACE, Kansas City, KS 66205
- EIN
- 86-3825535
- Ticker
- CING, CINGW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Cingulate Inc. on the corporate pages
On this site
- Form D issuer: Cingulate Inc. EXACT (CIK (EXACT))
- SEC filer: Cingulate Inc. EXACT (CIK (EXACT))
Filings 47
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-09-09 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-21-022284 ↗ |
| 2021-09-27 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-21-023793 ↗ |
| 2021-10-01 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-21-024275 ↗ |
| 2021-10-12 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-21-025132 ↗ |
| 2021-11-10 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-21-027764 ↗ |
| 2021-11-30 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-21-030052 ↗ |
| 2021-12-07 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-21-004589 ↗ |
| 2021-12-09 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-21-030966 ↗ |
| 2022-04-19 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-22-001018 ↗ |
| 2022-04-20 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-22-010536 ↗ |
| 2023-01-13 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-23-000112 ↗ |
| 2023-03-10 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-23-007265 ↗ |
| 2023-03-30 | RW | RW (withdrawal request) | Cingulate Inc. | 0001493152-23-009594 ↗ |
| 2023-04-26 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-23-013709 ↗ |
| 2023-05-02 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-23-015192 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-23-001241 ↗ |
| 2023-05-17 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-23-001455 ↗ |
| 2023-05-19 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-23-018198 ↗ |
| 2023-07-25 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-23-025442 ↗ |
| 2023-08-22 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-23-029773 ↗ |
| 2023-08-29 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-23-030578 ↗ |
| 2023-09-07 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-23-031913 ↗ |
| 2023-09-11 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-23-002620 ↗ |
| 2023-09-12 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-23-032349 ↗ |
| 2023-11-15 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-23-041403 ↗ |
| 2023-12-06 | RW | RW (withdrawal request) | Cingulate Inc. | 0001493152-23-043789 ↗ |
| 2024-01-12 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-24-002224 ↗ |
| 2024-01-29 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-24-004075 ↗ |
| 2024-02-02 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-000306 ↗ |
| 2024-02-05 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-24-004951 ↗ |
| 2024-04-02 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-000833 ↗ |
| 2024-04-03 | 424B4 | 424B4 (final prospectus) | Cingulate Inc. | 0001493152-24-012909 ↗ |
| 2024-05-17 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-24-020472 ↗ |
| 2024-05-23 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-001642 ↗ |
| 2024-07-24 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-002266 ↗ |
| 2024-08-19 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-24-032942 ↗ |
| 2024-08-27 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-002653 ↗ |
| 2024-09-27 | S-1 | S-1 (registration) | Cingulate Inc. | 0001493152-24-038400 ↗ |
| 2024-10-03 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-24-039276 ↗ |
| 2024-10-07 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001493152-24-039655 ↗ |
| 2024-10-07 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-24-003114 ↗ |
| 2025-07-22 | S-1 | S-1 (registration) | Cingulate Inc. | 0001641172-25-020622 ↗ |
| 2025-07-25 | S-1/A | S-1/A (amendment) | Cingulate Inc. | 0001641172-25-021016 ↗ |
| 2025-07-29 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-25-002396 ↗ |
| 2026-03-24 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-26-000923 ↗ |
| 2026-03-26 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-26-000956 ↗ |
| 2026-04-24 | EFFECT | EFFECT (declared effective) | Cingulate Inc. | 9999999995-26-001327 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Brams Matthew | Officer | EVP and Chief Medical Officer; EVP & Chief Medical Officer | 16 | 2021–2026 | |
| Callahan Jennifer L. | Officer | Corporate Controller; EVP and CFO; SVP and CFO | 20 | 2021–2026 | |
| Conroy Jeffrey X | Director | 3 | 2021–2022 | ||
| Fountainhead Shrugged, LLC | TenPercentOwner | 1 | 2021 | ||
| Gallagher Patrick Joseph | Director | 4 | 2021–2023 | ||
| Gilgallon Craig S. | Officer | EVP and General Counsel; EVP, GC and Secretary; EVP & General Counsel | 6 | 2021–2023 | |
| GIVENS GREGG WM | Director | 7 | 2021–2023 | ||
| Hargroves Thomas Jeffrey | Director | 7 | 2021–2026 | ||
| Medeiros Curtis | Director | 6 | 2021–2023 | ||
| Myers Laurie | Officer | EVP and COO; EVP & Chief Operating Officer | 15 | 2021–2025 | |
| Schaffer Shane J. | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 16 | 2021–2026 | |
| Silva Raul R. | Officer | EVP and Chief Science Officer; EVP and CSO; EVP & Chief Science Officer | 26 | 2021–2026 | |
| VAN HORN LOUIS G | Officer | EVP and CFO; EVP & Chief Financial Officer | 5 | 2021–2023 | |
| Werth Family Investment Associates LLC | TenPercentOwner | 6 | 2021–2024 | ||
| Werth Peter J. | Director; Director,TenPercentOwner | 18 | 2021–2026 | ||
| Applebaum Scott | Director | 3 | 2022–2023 | ||
| Ervin Jeffrey S | Director | 4 | 2024–2025 | ||
| Lawrence Bryan Jay | Director | 5 | 2024–2026 | ||
| ROBERTS JOHN A | Director | 4 | 2024–2025 | ||
| Patel Nilay Dahyabhai | Officer | CLO and CCO; CLO & CCO; EVP, CLO and CCO | 3 | 2025–2026 | |
| Downey Bryan Wade | Officer | Chief Commercial Officer; EVP & Chief Commercial Officer | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-09-28 | Cingulate Inc. | Pharmaceuticals | $220,000,000 | $0 | 0 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.